Giuseppe Carli

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano et al. · The Lancet Haematology · 2021 · 132 citations · Full text

Medicine, Hematology, Pharmacotherapy +6

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

Bianca Rocca, Alberto Tosetto, Denise Soldati et al. · Blood · 2020 · 104 citations · Full text

Medicine, Hematology, Pharmacology +14

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

Tiziano Barbui, Arianna Ghirardi, Arianna Masciulli et al. · Leukemia · 2019 · 91 citations · Full text

Medicine, Hematology, Oncology +16

Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients

Olivia Marini, Cecilia Spina, Elda Mimiola et al. · Oncotarget · 2016 · 89 citations · Full text

Medicine, Hematology, Pathology +17

Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

Tiziano Barbui, Valerio De Stefano, Alessandra Carobbio et al. · Leukemia · 2021 · 59 citations · Full text

Medicine, Hematology, Pharmacology +14